• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    ChemoCentryx, Inc. (CCXI)

    -NasdaqGS
    8.83 Up 0.08(0.91%) Jan 27, 4:00PM EST
    |After Hours : 8.83 0.00 (0.00%) Jan 27, 4:50PM EST
    Add to Portfolio
    Prev Close:8.75
    Open:8.71
    Bid:6.08 x 800
    Ask:N/A
    1y Target Est:8.33
    Beta:0.82
    Next Earnings Date:N/A
    Day's Range:8.50 - 9.00
    52wk Range:4.06 - 9.00
    Volume:293,715
    Avg Vol (3m):354,835
    Market Cap:382.69M
    P/E (ttm):N/A
    EPS (ttm):-1.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CCXI

    Comparison

    Symbol% ChgMkt Cap
    CCXIUp 0.91%382.69M
    ABTDown 1.06%65.77B
    AMGNDown 0.53%120.86B
    AZNUp 1.87%90.80B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):523.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.10
    Quarterly EPS Est (Dec-14) :-0.29
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback